Open-Label Extension to Evaluate the Longer Term Efficacy and Safety of LIB003
Clinical trial NCT03847974 · COMPLETED
Trial details
- NCT number
- NCT03847974
- Sponsor
- LIB Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-14
- Primary completion
- 2020-04-07
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.